Therapeutic Advances in Chronic Disease

Aims & Scope

Therapeutic Advances in Chronic Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of all chronic diseases.

The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in chronic disease, providing an online forum for rapid dissemination of recent research and perspectives in this area.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,950.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease

  Citation: 260

  Authors: Leena, Christopher E.

• Obstructive sleep apnoea syndrome and its management

  Citation: 232

  Authors: Lucia, Daniela, Giuseppe

• Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses

  Citation: 222

  Authors: Rajesh R., Deena J., Silpa, Shilpa

• Epidemiology of sarcoidosis: current findings and future directions

  Citation: 206

  Authors: Elizabeth V., Yvette C.

• Early onset type 2 diabetes: risk factors, clinical impact and management

  Citation: 200

  Authors: Emma, Iskandar

• Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians

  Citation: 197

  Authors: Vèronique, Christine

• Neurological manifestations of long-COVID syndrome: a narrative review

  Citation: 187

  Authors: Maria-Ioanna, Lina, Eleni, Nikolaos, Marianna, George P., Emmanouil, Eleni, Nikolaos, Christos, Sotirios, Sotirios, Mina, Georgios

• Radiation-induced small bowel disease: latest developments and clinical guidance

  Citation: 175

  Authors: Rhodri, John T.

• Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

  Citation: 172

  Authors: Nicolas D., Mark J., Erica M., Jennifer L., Elizabeth D., Nancy B., Allison C., Rodrigo, Carlos A.

• Treatment of painful diabetic neuropathy

  Citation: 172

  Authors: Saad, Ioannis N., Uazman, Rayaz A.